Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.
Open Access
- 1 June 1997
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 34 (6), 525-526
- https://doi.org/10.1136/jmg.34.6.525
Abstract
A common missense mutation in the methylenetetrahydrofolate reductase (MTHFR) gene, a C to T substitution at nucleotide 677, is responsible for reduced MTHFR activity and associated with modestly increased plasma homocysteine concentrations. Since underlying maternal vascular disease increases the risk of pre-eclampsia, we had the working hypothesis that pre-eclampsia patients would have an increased T677 allele frequency compared with controls. The MTHFR genotypes were determined in 67 pre-eclampsia patients, 98 normal pregnant women, and 260 healthy adults by the PCR/RFLP method. The T677 allele and the genotype homozygous for the T677 allele were significantly increased in the pre-eclamptic group compared with the controls (p < 0.02 and p < 0.004, respectively). The data indicate that the T677 variant of the MTHFR gene is one of the genetic risk factors for pre-eclampsia.Keywords
This publication has 4 references indexed in Scilit:
- Homocysteine and vascular diseaseNature Medicine, 1996
- Underlying disorders associated with severe early-onset preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentaeThe Lancet, 1992